The legacy of Viagra and its impact on the pharmaceutical landscape presents a intriguing question for shareholders . Initially a hugely successful drug, competitors have significantly diminished its market presence , creating difficulties for companies connected to the original patent holder and subsequent advancements . While certain companies mi